Literature DB >> 15486830

Paradoxical inflammatory reaction during treatment of Cryptococcus neoformans var. gattii meningitis in an HIV-seronegative woman.

Lloyd Einsiedel1, David L Gordon, John R Dyer.   

Abstract

A human immunodeficiency virus (HIV)-seronegative woman was admitted to the hospital with postpartum onset Cryptococcus neoformans var. gattii meningitis and markedly increased intracranial pressure. A poor initial response to antifungal therapy was followed, 2 months after hospital admission, by severe acute meningeal and cerebral inflammation and clearance of yeast cells from cerebrospinal fluid. This first reported case of paradoxical inflammatory reaction to C. neoformans illustrates important aspects of the host-pathogen interaction and highlights possible effects of immunomodulatory therapies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15486830     DOI: 10.1086/424746

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  25 in total

1.  [Immune reconstitution syndrome].

Authors:  D Meyer-Olson; D Ernst; M Stoll
Journal:  Z Rheumatol       Date:  2012-04       Impact factor: 1.372

2.  Of mice and men, revisited: new insights into an ancient molecule from studies of complement activation by Cryptococcus neoformans.

Authors:  Liise-Anne Pirofski
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

Review 3.  Novel immune regulatory pathways and their role in immune reconstitution syndrome in organ transplant recipients with invasive mycoses.

Authors:  N Singh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-01-23       Impact factor: 3.267

4.  Dendritic cell-based immunization ameliorates pulmonary infection with highly virulent Cryptococcus gattii.

Authors:  Keigo Ueno; Yuki Kinjo; Yoichiro Okubo; Kyoko Aki; Makoto Urai; Yukihiro Kaneko; Kiminori Shimizu; Dan-Ni Wang; Akiko Okawara; Takuya Nara; Kayo Ohkouchi; Yuki Mizuguchi; Susumu Kawamoto; Katsuhiko Kamei; Hideaki Ohno; Yoshihito Niki; Kazutoshi Shibuya; Yoshitsugu Miyazaki
Journal:  Infect Immun       Date:  2015-02-02       Impact factor: 3.441

5.  Tuberculosis-associated hemophagocytic lymphohistiocytosis with subsequent unmasking cryptococcal immune reconstitution inflammatory syndrome (IRIS) in an HIV-negative man.

Authors:  Hilte F Geerdes-Fenge; Micha Löbermann; Christoph J Hemmer; Orsolya Benedek; Emil C Reisinger
Journal:  Infection       Date:  2018-09-26       Impact factor: 3.553

6.  Fungal brain infection modelled in a human-neurovascular-unit-on-a-chip with a functional blood-brain barrier.

Authors:  Jin Kim; Kyung-Tae Lee; Jong Seung Lee; Jisoo Shin; Baofang Cui; Kisuk Yang; Yi Sun Choi; Nakwon Choi; Soo Hyun Lee; Jae-Hyun Lee; Yong-Sun Bahn; Seung-Woo Cho
Journal:  Nat Biomed Eng       Date:  2021-06-14       Impact factor: 25.671

Review 7.  Cryptococcus gattii infections.

Authors:  Sharon C-A Chen; Wieland Meyer; Tania C Sorrell
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

8.  Clinical presentation, diagnosis and management of Cryptococcus gattii cases: Lessons learned from British Columbia.

Authors:  Eleni Galanis; Linda Hoang; Pamela Kibsey; Muhammad Morshed; Peter Phillips
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

9.  Phenotypic switching in Cryptococcus neoformans contributes to virulence by changing the immunological host response.

Authors:  Abraham Guerrero; Bettina C Fries
Journal:  Infect Immun       Date:  2008-06-30       Impact factor: 3.441

10.  Predictors of immune reconstitution syndrome in organ transplant recipients with cryptococcosis: implications for the management of immunosuppression.

Authors:  Hsin-Yun Sun; Barbara D Alexander; Shirish Huprikar; Graeme N Forrest; Didier Bruno; G Marshall Lyon; Dannah Wray; Leonard B Johnson; Costi D Sifri; Raymund R Razonable; Michele I Morris; Valentina Stosor; Marilyn M Wagener; Nina Singh
Journal:  Clin Infect Dis       Date:  2014-09-09       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.